We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-1.17%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.57B
AUM Growth
-$475M
Cap. Flow
-$414M
Cap. Flow %
-26.4%
Top 10 Hldgs %
3.64%
Holding
2,143
New
360
Increased
540
Reduced
709
Closed
519

Sector Composition

Rank Sector Weight
1 Healthcare 16.12%
2 Consumer Discretionary 13.55%
3 Industrials 13.42%
4 Technology 11.37%
5 Financials 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNH
26
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$3.87M 0.25%
93,931
+6,765
+8% +$279K
SUPN icon
27
Supernus Pharmaceuticals
SUPN
$2.7B
$3.85M 0.25%
252,109
+32,537
+15% +$425K
RGR icon
28
Sturm, Ruger & Co
RGR
$603M
$3.84M 0.24%
56,112
+17,912
+47% +$1.17M
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$123B
$3.82M 0.24%
+48,006
New +$4.34M
USNA icon
30
Usana Health Sciences
USNA
$419M
$3.81M 0.24%
62,678
-8,434
-12% -$497K
HD icon
31
Home Depot
HD
$337B
$3.75M 0.24%
28,134
+1,143
+4% +$142K
AVP
32
DELISTED
Avon Products, Inc.
AVP
$3.75M 0.24%
779,404
-37,900
-5% -$135K
ENTA icon
33
Enanta Pharmaceuticals
ENTA
$362M
$3.72M 0.24%
126,675
+46,353
+58% +$1.29M
IQV icon
34
IQVIA
IQV
$40.7B
$3.7M 0.24%
56,817
-12,503
-18% -$791K
FPRX
35
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3.69M 0.24%
90,862
+18,662
+26% +$641K
GOOGL icon
36
Alphabet (Google) Class A
GOOGL
$4.12T
$3.67M 0.23%
96,280
-231,640
-71% -$8.53M
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.65M 0.23%
25,692
+9,630
+60% +$1.28M
TEL icon
38
TE Connectivity
TEL
$60B
$3.64M 0.23%
58,798
+35,356
+151% +$2.05M
AAPL icon
39
Apple
AAPL
$4.97T
$3.58M 0.23%
131,248
-27,348
-17% -$681K
ARLP icon
40
Alliance Resource Partners
ARLP
$3.34B
$3.57M 0.23%
306,087
+99,190
+48% +$1.21M
ZIXI
41
DELISTED
Zix Corporation
ZIXI
$3.56M 0.23%
907,109
+42,332
+5% +$177K
UPBD icon
42
Upbound Group
UPBD
$1.22B
$3.54M 0.23%
223,045
+42,564
+24% +$568K
UTHR icon
43
United Therapeutics
UTHR
$26.1B
$3.5M 0.22%
31,429
+2,158
+7% +$273K
VLO icon
44
Valero Energy
VLO
$89.5B
$3.47M 0.22%
54,114
+18,944
+54% +$1.2M
SCLN
45
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$3.43M 0.22%
312,115
-13,000
-4% -$116K
BGFV
46
DELISTED
Big 5 Sporting Goods
BGFV
$3.39M 0.22%
304,814
-34,540
-10% -$404K
ENVA icon
47
Enova International
ENVA
$6.09B
$3.34M 0.21%
529,277
+62,644
+13% +$374K
META icon
48
Meta Platforms (Facebook)
META
$1.49T
$3.33M 0.21%
29,153
-130,630
-82% -$13.8M
TBRG
49
DELISTED
TruBridge
TBRG
$3.31M 0.21%
63,457
-20,121
-24% -$1.07M
ACN icon
50
Accenture
ACN
$106B
$3.3M 0.21%
28,609
+16,811
+142% +$1.73M

Similar funds

GSA Capital Partners's Q1 2016 Portfolio in Review

As of Q1 2016, GSA Capital Partners held 2,143 positions worth $1.57B, down 23% from $2.04B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners withdrew a net $414M in Q1 2016, closing 519 positions and reducing 709 holdings. Its most notable exit was Chipotle Mexican Grill, an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Macerich worth $4.66M.

  • GSA Capital Partners's largest Q1 2016 buy was Macerich: 58,787 shares worth $4.66M.
  • GSA Capital Partners added most to Bausch Health in Q1 2016, an estimated $16.2M increase.
  • GSA Capital Partners's biggest Q1 2016 reduction was Meta Platforms (Facebook), cutting an estimated $13.8M.
  • GSA Capital Partners fully exited Chipotle Mexican Grill in Q1 2016, selling an estimated $20.9M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.57B portfolio in Q1 2016.
  • GSA Capital Partners opened 360 new positions and closed 519 in Q1 2016.
  • GSA Capital Partners's portfolio value fell 23% quarter-over-quarter to $1.57B.

Based on GSA Capital Partners's 13F filing for Q1 2016, filed 11 May 2016.